Efficacy and safety of continued zoledronic acid every 4 weeks versus every 12 weeks in women with bone metastases from breast cancer Results of the OPTIMIZE-2 trial – OncoPrescribe
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
Bisphosphonates as antimyeloma drugs | Leukemia
Frontiers | Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
Cancers | Free Full-Text | Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments
Cureus | Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment | Article
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
Prolia® (denosumab) Mechanism of Action | Prolia®
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy | SpringerLink
Cancers | Free Full-Text | Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Semantic Scholar
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy | ACS Biomaterials Science & Engineering
Zoledronic acid | New Drug Approvals
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library
Mechanism of action of abiraterone acetate, enzalutamide, radium-223... | Download Scientific Diagram
Zoledronic acid - Wikipedia
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma | Bentham Science
